Publications
| Title | Abstract | Year Filter | PMID(sorted descending) Filter |
|---|
| bioterrorism on the home front: a new challenge for american medicine. | 2001 | 11722275 | |
| death due to bioterrorism-related inhalational anthrax: report of 2 patients. | on october 9, 2001, a letter containing anthrax spores was mailed from new jersey to washington, dc. the letter was processed at a major postal facility in washington, dc, and opened in the senate's hart office building on october 15. between october 19 and october 26, there were 5 cases of inhalational anthrax among postal workers who were employed at that major facility or who handled bulk mail originating from that facility. the cases of 2 postal workers who died of inhalational anthrax are r ... | 2001 | 11722269 |
| clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. | the use of anthrax as a weapon of biological terrorism has moved from theory to reality in recent weeks. following processing of a letter containing anthrax spores that had been mailed to a us senator, 5 cases of inhalational anthrax have occurred among postal workers employed at a major postal facility in washington, dc. this report details the clinical presentation, diagnostic workup, and initial therapy of 2 of these patients. the clinical course is in some ways different from what has been d ... | 2001 | 11722268 |
| anthrax: a motor protein determines anthrax susceptibility. | a new study has found that polymorphisms in the host gene kif1c, which encodes a kinesin-like motor protein, determine whether mouse macrophages are resistant or sensitive to anthrax lethal toxin. these findings may lead the way to discovering how both germ and host factors might contribute to a lethal infection. | 2001 | 11719234 |
| the loss of innocence. | 2001 | 11718352 | |
| bioterrorism in the united states: take it seriously. | 2001 | 11718117 | |
| hyping bioterrorism obscures real concerns. | 2001 | 11718116 | |
| crystallization and preliminary x-ray study of the edema factor exotoxin adenylyl cyclase domain from bacillus anthracis in the presence of its activator, calmodulin. | edema factor from bacillus anthracis is a 92 kda secreted adenylyl cyclase exotoxin and is activated by the host-resident protein calmodulin. calmodulin is a ubiquitous intracellular calcium sensor in eukaryotes and activates edema factor nearly 1000-fold upon binding. while calmodulin has many known effectors, including kinases, phosphodiesterases, motor proteins, channels and type 1 adenylyl cyclases, no structures of calmodulin in complex with a functional enzyme have been solved. the crystal ... | 2001 | 11717504 |
| anthrax as a cancer drug? | 2001 | 11717324 | |
| anthrax. the mystery deepens. | 2001 | 11715914 | |
| who should get flu shots? | 2001 | 11715913 | |
| [this concerns your patients. how does one recognize anthrax? (interview by dr. roland knauer)]. | 2001 | 11715871 | |
| bugs, bared. genome sequences of killer microbes reveal the arsenals of infection. | 2001 | 11715870 | |
| counting deadly spores. | 2001 | 11715866 | |
| clueless in manhattan. | 2001 | 11715865 | |
| cdc has anthrax, smallpox vaccination guidelines available. | 2001 | 11715817 | |
| life on alert. nation remains jittery as threats keep coming. | 2001 | 11715791 | |
| how little we really know. | 2001 | 11715747 | |
| sketchy isn't best. hospitals fault feds for poor anthrax guidance. | 2001 | 11715739 | |
| mapping the anthrax protective antigen binding site on the lethal and edema factors. | entry of anthrax edema factor (ef) and lethal factor (lf) into the cytosol of eukaryotic cells depends on their ability to translocate across the endosomal membrane in the presence of anthrax protective antigen (pa). here we report attributes of the n-terminal domains of ef and lf (ef(n) and lf(n), respectively) that are critical for their initial interaction with pa. we found that deletion of the first 36 residues of lf(n) had no effect on its binding to pa or its ability to be translocated. to ... | 2002 | 11714723 |
| anthrax battle continues; office of public health preparedness emerges. | 2001 | 11713771 | |
| bioterrorism. labs tighten security, regardless of need. | 2001 | 11711648 | |
| scientists against biological weapons. | 2001 | 11711640 | |
| see this goop? it kills anthrax. | 2001 | 11710273 | |
| what you should know. confusion about anthrax and what to do about it abounds; here are answers, straight and up to date. | 2001 | 11710270 | |
| into the zone of the unknown. it's been the blind leading the blind through the maze of anthrax. | 2001 | 11710269 | |
| anthrax nation. | 2001 | 11710268 | |
| 'i need scientists!'. | 2001 | 11710160 | |
| protecting america. the top 10 priorities. | 2001 | 11710159 | |
| the hunt for the anthrax killers. | 2001 | 11710155 | |
| interim recommendations for protecting workers from exposure to bacillus anthracis in work sites in which mail is handled or processed. | cdc has developed interim recommendations to assist personnel responsible for occupational health and safety in developing a comprehensive program to reduce potential cutaneous or inhalational exposures to bacillus anthracis spores among workers in work sites in which mail is handled or processed. such work sites include post offices, mail distribution/handling centers, bulk mail centers, air mail facilities, priority mail processing centers, public and private mail rooms, and other settings in ... | 2001 | 11708595 |
| updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to bacillus anthracis. | the antimicrobial of choice for initial prophylactic therapy among asymptomatic pregnant women exposed to bacillus anthracis is ciprofloxacin, 500 mg twice a day for 60 days. in instances in which the specific b. anthracis strain has been shown to be penicillin-sensitive, prophylactic therapy with amoxicillin, 500 mg three times a day for 60 days, may be considered. isolates of b. anthracis implicated in the current bioterrorist attacks are susceptible to penicillin in laboratory tests, but may ... | 2001 | 11708594 |
| update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. | since october 3, 2001, cdc and state and local public health authorities have been investigating cases of bioterrorism-related anthrax. this report updates findings as of october 31, and includes interim guidelines for the clinical evaluation of persons with possible anthrax. a total of 21 cases (16 confirmed and five suspected) of bioterrorism-related anthrax have been reported among persons who worked in the district of columbia, florida, new jersey, and new york city (figure 1). until the sou ... | 2001 | 11708591 |
| pediatric implications in bioterrorism part ii: postexposure diagnosis and treatment. | bioterrorism is an old tactic used in warfare. the use of fatal diseases or man-made poisons to subdue others has not been limited to wartime. trauma personnel should be aware of commonly used agents, the signs and symptoms of their exposure, and recommended treatment. children can be victims of terrorists' acts and need special attention because of their unique response to exposure, varying dosages of medications, and lack of active immunity. | 2001 | 11707769 |
| anthrax in usa--attacks "deadly but treatable". | 2001 | 11705575 | |
| us anthrax scares prompt action on bioterrorism. | 2001 | 11705502 | |
| letter in pakistan tests positive for anthrax spores. | 2001 | 11705501 | |
| risk of deliberately induced anthrax outbreak. | 2001 | 11705480 | |
| recognition and management of anthrax--an update. | 2001 | 11704686 | |
| index case of fatal inhalational anthrax due to bioterrorism in the united states. | 2001 | 11704685 | |
| images in clinical medicine. cutaneous anthrax infection. | 2001 | 11704684 | |
| cutaneous bacillus anthracis infection. | 2001 | 11704683 | |
| experts doubts us is ready for biowarfare attack. | 2001 | 11702725 | |
| anthrax. | 2001 | 11702421 | |
| chemistry. nota bene: know thine enemy. | 2001 | 11701920 | |
| anthrax. biodefense hampered by inadequate tests. | 2001 | 11701907 | |
| counterterrorism. u.s. enlists researchers as fight widens against bioterrorism. | 2001 | 11701894 | |
| crystal structure of the anthrax lethal factor. | lethal factor (lf) is a protein (relative molecular mass 90,000) that is critical in the pathogenesis of anthrax. it is a highly specific protease that cleaves members of the mitogen-activated protein kinase kinase (mapkk) family near to their amino termini, leading to the inhibition of one or more signalling pathways. here we describe the crystal structure of lf and its complex with the n terminus of mapkk-2. lf comprises four domains: domain i binds the membrane-translocating component of anth ... | 2001 | 11700563 |
| identification of the cellular receptor for anthrax toxin. | the tripartite toxin secreted by bacillus anthracis, the causative agent of anthrax, helps the bacterium evade the immune system and can kill the host during a systemic infection. two components of the toxin enzymatically modify substrates within the cytosol of mammalian cells: oedema factor (of) is an adenylate cyclase that impairs host defences through a variety of mechanisms including inhibiting phagocytosis; lethal factor (lf) is a zinc-dependent protease that cleaves mitogen-activated prote ... | 2001 | 11700562 |
| tackling anthrax. | 2001 | 11700539 | |
| universities address mail security as anthrax fears rise. | 2001 | 11700511 | |
| update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, october 2001. | since october 3, 2001, cdc and state and local public health authorities have been investigating cases of bioterrorism-related anthrax. this report updates previous findings, provides new information on case investigations in two additional areas, presents the susceptibility patterns of bacillus anthracis isolates, and provides interim recommendations for managing potential threats and exposures and for treating anthrax. | 2001 | 11699843 |
| attempts to stem anthrax fears stumble. | 2001 | 11699540 | |
| war on terror. epidemic threats. | 2001 | 11699429 | |
| war on terror: biochem. tracking anthrax. | 2001 | 11699428 | |
| confusion in spades. the anthrax scares reveal a public-health system in disarray. | 2001 | 11699231 | |
| a no-show vaccine--for a mere $126 million. deal? | 2001 | 11699229 | |
| tools of mass distraction. | 2001 | 11699228 | |
| perspectives. terrorism event no time to be learning on the job. | 2001 | 11699157 | |
| be a patriot. don't hoard cipro! | 2001 | 11699135 | |
| a dose of reality for the health watchdogs. | 2001 | 11699134 | |
| homeland insecurity. | 2001 | 11699131 | |
| anthrax, united states of america (update). | 2001 | 11697083 | |
| bayer cuts price of ciprofloxacin after bush threatens to buy generics. | 2001 | 11691754 | |
| toll of anthrax cases reaches 15. | 2001 | 11691753 | |
| how anthrax gets a grip on cells. | 2001 | 11691752 | |
| prophylactic treatment of anthrax with antibiotics. | 2001 | 11691746 | |
| science marshalled to cut bioterror confusion. | 2001 | 11689904 | |
| crackdown on hazardous agents raises concern for bona fide labs. | 2001 | 11689899 | |
| bioterrorism threat becomes reality. | 2001 | 11689863 | |
| a battle cry for biomedicine. | 2001 | 11689860 | |
| us expands anti-bioterrorist measures. | 2001 | 11689831 | |
| post-exposure anthrax prophylaxis. | 2001 | 11689760 | |
| recognition of illness associated with the intentional release of a biologic agent. | on september 11, 2001, following the terrorist incidents in new york city and washington, d.c., cdc recommended heightened surveillance for any unusual disease occurrence or increased numbers of illnesses that might be associated with the terrorist attacks. subsequently, cases of anthrax in florida and new york city have demonstrated the risks associated with intentional release of biologic agents. this report provides guidance for health-care providers and public health personnel about recogniz ... | 2001 | 11686473 |
| update: investigation of anthrax associated with intentional exposure and interim public health guidelines, october 2001. | on october 4, 2001, cdc and state and local public health authorities reported a case of inhalational anthrax in florida. additional cases of anthrax subsequently have been reported from florida and new york city. this report updates the findings of these case investigations, which indicate that infections were caused by the intentional release of bacillus anthracis. this report also includes interim guidelines for postexposure prophylaxis for prevention of inhalational anthrax and other informa ... | 2001 | 11686472 |
| bioterrorism: safeguarding the public's health. | 2001 | 11684202 | |
| protecting yourself. | 2001 | 11682958 | |
| a new state of fear. | 2001 | 11682956 | |
| anthrax. deadly delivery. | 2001 | 11682912 | |
| shadow of fear. | 2001 | 11682911 | |
| danger: handle with care. | 2001 | 11682910 | |
| war on terror. a run on antibiotics. | 2001 | 11682909 | |
| war on terror. anxious about anthrax. | 2001 | 11682908 | |
| bioterrorism. researchers question obsession with cipro. | 2001 | 11679638 | |
| anthrax blamed as two postal workers die in united states. | 2001 | 11679374 | |
| preparedness and response to bioterrorism. | as we enter the 21st century the threats of biological warfare and bioterrorism (so called asymmetric threats) appear to be more real than ever before. historical evidence suggests that biological weapons have been used, with varying degrees of success, for many centuries. despite the international agreements to ban such weapons, namely the 1925 geneva protocol and the 1975 biological and toxin weapons convention, there is no effective international mechanism for challenging either the developme ... | 2001 | 11676515 |
| human anthrax in india: urgent need for effective prevention. | anthrax is a zoonotic illness caused by bacillus anthracis. sporadic cases continue to be reported from many parts of the world. from india, both sporadic cases and outbreaks are being reported regularly. the union territory of pondicherry (a former french colony) lies on the coast of bay of bengal, where the incidence of anthrax is on the rise with 28 cases being detected in the year 1999 and 2000 alone. so far, about 34 human cases have been encountered in this region. recently, an increase in ... | 2000 | 11668934 |
| uk doctors given guidance on dealing with anthrax. | 2001 | 11668123 | |
| us fear of bioterrorism spreads as anthrax cases increase. | 2001 | 11668122 | |
| appropriate responses to bioterrorist threats. | 2001 | 11668117 | |
| airman discharged for refusal to take anthrax vaccine as rebellion grows. | 1999 | 11647631 | |
| bioterrorism. vaccines for biodefense: a system in distress. | 2001 | 11641476 | |
| bioterrorism. this time it was real: knowledge of anthrax put to the test. | 2001 | 11641469 | |
| the 1919 anthrax outbreak in louisiana. | 2000 | 11640246 | |
| the control of woolsorter's disease. | 1975 | 11630665 | |
| [not available]. | 1978 | 11627960 | |
| [not available]. | 1973 | 11626873 | |
| [zoeros pasha's report presented to the sultinate on his return from paris]. | the ottoman empire dispatched a committee consisting of zoeros pasha, the president, dr. hüseyin remzi and veterinarian hüseyin hüsnü, who were members sent to learn how the method of the vaccination of rabies was practiced in paris in 1886. zoeros pasha relates their studies in paris, as well as his idea on the novelties he observed there and comments on the advantages of them in case of application in the empire, in his report dated december 29th of 1886, prepared on his return from paris. zoe ... | 1995 | 11625087 |
| diseases revisited, or anthrax and bovine spongiform encephalopathy. | 1992 | 11623149 | |
| [anthrax: a malady of animals and of man which hides in the earth]. | anthrax is an infectious disease of herbivores, especially sheep and cattle, but also of horses, of pigs, of dogs, of wild animals and of humans. bacillus anthracis causes the disease. this bacterium needs plenty of oxygen to procreate and to produce resistant spores, which remains viable in the soil during 3.5 years, at times during 15-20 years. the author tries to follow step by step the evolution of the ideas concerning the origin and the pathology as well as of the veterinarians measures ag ... | 1997 | 11619781 |